Dow Down0.35% Nasdaq Up0.15%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
53.73 Up 1.69(3.25%) 2:31PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 10,608   15,958   14,736   13,006  
Cost of Revenue1,186  2,451  1,316  2,539  
Gross Profit 9,422   13,507   13,420   10,467  
Operating Expenses
Research Development2,690  3,131  2,374  2,413  
Selling General and Administrative5,238  5,072  4,420  4,756  
Non Recurring136  204  201  227  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 1,358   5,100   6,425   3,071  
Income from Continuing Operations
Total Other Income/Expenses Net63  (2,702)(4,097)(651)
Earnings Before Interest And Taxes1,421  2,398  2,328  2,420  
Interest Expense181  248  322  394  
Income Before Tax1,240  2,150  2,006  2,026  
Income Tax Expense(47)53  137  61  
Minority Interest -   -   -   -  
Net Income From Continuing Ops1,287  2,097  1,869  1,965  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 1,287   2,097   1,869   1,965  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 1,591   2,097   1,869   1,965  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.